We’re excited to announce that our CEO, Sylvain Yon, will attend RESI Europe Conference 2025, connecting with global investors and partners in healthcare innovation.
A great opportunity for Mabqi to showcase its portfolio of first-in-class and best-in-class proprietary functional antibodies with high therapeutic potential in oncology (including pH-sensitive antibodies and ADCs).
📍 Join us on April 1, 2025, at The InterContinental Barcelona, followed by two days of virtual partnering on April 2-3, 2025.
👉 Interested in learning more about our pipeline and lead antibody programs? Request a meeting now!
